BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

542934

CBPL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Chandra Bhagat Pharma Limited Share Price Update

As of the latest trading session, Chandra Bhagat Pharma Limited share price is currently at ₹ 60, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 60.00 and ₹ 60.00. Over the past year, Chandra Bhagat Pharma Limited has achieved a return of -47.75 %. In the last month alone, the return has been -7.69 %. Read More...

Chandra Bhagat Pharma Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    45.30

  • P/E Ratio (TTM)

    29.56

  • Beta

    -1.04

  • Book Value / share

    38.44

  • Return on equity

    5.42%

  • EPS (TTM)

    2.03

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Chandra Bhagat Pharma Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 221.37
Operating Expense 230.45
Net Profit 1.53
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 2.03
EBITDA 4.28
Effective Tax Rate (%) 32.30
Particulars MAR 2023 (Values in Cr)
Revenue 119.67
Operating Expense 118.81
Net Profit 0.91
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 1.20
EBITDA 3.61
Effective Tax Rate (%) 22.41
Particulars MAR 2022 (Values in Cr)
Revenue 94.08
Operating Expense 94.60
Net Profit 0.80
Net Profit Margin (%) 0.85
Earnings Per Share (EPS) 1.06
EBITDA 4.30
Effective Tax Rate (%) 27.27
Particulars MAR 2021 (Values in Cr)
Revenue 70.70
Operating Expense 70.89
Net Profit 0.19
Net Profit Margin (%) 0.26
Earnings Per Share (EPS) 0.25
EBITDA 3.78
Effective Tax Rate (%) 32.14
Particulars MAR 2020 (Values in Cr)
Revenue 93.98
Operating Expense 94.00
Net Profit 0.31
Net Profit Margin (%) 0.32
Earnings Per Share (EPS) 0.55
EBITDA 3.51
Effective Tax Rate (%) 26.19
Particulars MAR 2024 (Values in Cr)
Book Value / Share 38.45
ROE % 5.42
ROCE % 7.73
Total Debt to Total Equity 0.63
EBITDA Margin 1.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 36.42
ROE % 3.36
ROCE % 6.83
Total Debt to Total Equity 0.74
EBITDA Margin 3.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 35.35
ROE % 3.04
ROCE % 8.14
Total Debt to Total Equity 0.92
EBITDA Margin 4.74
Particulars MAR 2021 (Values in Cr)
Book Value / Share 34.30
ROE % 0.74
ROCE % 6.95
Total Debt to Total Equity 1.11
EBITDA Margin 5.88
Particulars MAR 2020 (Values in Cr)
Book Value / Share 34.05
ROE % 1.54
ROCE % 6.43
Total Debt to Total Equity 1.52
EBITDA Margin 3.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.96
Total Assets 101.80
Total Liabilities 101.80
Total Equity 29.00
Share Outstanding 7545056
Price to Book Ratio 2.47
Return on Assets (%) 1.50
Return on Capital (%) 3.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.43
Total Assets 60.58
Total Liabilities 60.58
Total Equity 27.47
Share Outstanding 7545056
Price to Book Ratio 2.66
Return on Assets (%) 1.49
Return on Capital (%) 1.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.68
Total Assets 72.46
Total Liabilities 72.46
Total Equity 26.67
Share Outstanding 7545056
Price to Book Ratio 3.22
Return on Assets (%) 1.09
Return on Capital (%) 1.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.82
Total Assets 71.78
Total Liabilities 71.78
Total Equity 25.87
Share Outstanding 7545056
Price to Book Ratio 1.15
Return on Assets (%) 0.26
Return on Capital (%) 0.37
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 74.73
Total Liabilities 74.73
Total Equity 25.68
Share Outstanding 7545056
Price to Book Ratio 1.17
Return on Assets (%) 0.42
Return on Capital (%) 0.59
Particulars MAR 2024 (Values in Cr)
Net Income 2.26
Cash from Operations 6.63
Cash from Investing -1.85
Cash from Financing -5.79
Net change in Cash -1.47
Free Cash Flow 8.91
Particulars MAR 2023 (Values in Cr)
Net Income 1.16
Cash from Operations 5.59
Cash from Investing -0.05
Cash from Financing -4.44
Net change in Cash 0.75
Free Cash Flow 5.96
Particulars MAR 2022 (Values in Cr)
Net Income 1.09
Cash from Operations 12.50
Cash from Investing 0.08
Cash from Financing -9.62
Net change in Cash 2.86
Free Cash Flow 12.60
Particulars MAR 2021 (Values in Cr)
Net Income 0.27
Cash from Operations 8.42
Cash from Investing 0.11
Cash from Financing -6.42
Net change in Cash 2.02
Free Cash Flow 8.44
Particulars MAR 2020 (Values in Cr)
Net Income 0.42
Cash from Operations -7.41
Cash from Investing 0.05
Cash from Financing 6.93
Net change in Cash -0.42
Free Cash Flow -7.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2904.45 57.61 29.41 49203.14 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

Chandra Bhagat Pharma Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
60.00 9.09 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
60.00 PIVOT

First Support

60.00

First Resistance

60.00

Second Support

60.00

Second Resistance

60.00

Third Support

60.00

Third Resistance

60.00

RSI

47.62

ADX

10.86

MACD

0.00

Williams % R

-47.34

Commodity Channel Index (CCI)

-25.72

Date

2025-04-17

Week

1000.00

Same Day

1000.00

Month

9000.00

1 Year

-1.05

3 Year

-0.65

Over 1 Month

-7.69%

down

Over 1 Year

-47.75%

down

Over 3 Months

-9.09%

down

Over 3 Years

-19.80%

down

Over 6 Months

-4.91%

down

Over 5 Years

12.49%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Chandra Bhagat Pharma Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
28.19%
Promoter Holdings
71.19%
FII
0.6%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Hemant Chandravadan Bhagat 2678296.0 (35.5%) Shareholding of Promoter and Promoter Group
Chitra Hemant Bhagat 1233192.0 (16.34%) Shareholding of Promoter and Promoter Group
Pranav Hemant Bhagat 761792.0 (10.1%) Shareholding of Promoter and Promoter Group
Team Anamika Algo Limited 717000.0 (9.5%) Public Shareholding
Prachi Pranav Bhagat 266600.0 (3.53%) Shareholding of Promoter and Promoter Group
Hemant C Bhagat Huf 148576.0 (1.97%) Shareholding of Promoter and Promoter Group
Mahesh C Bhagat 120000.0 (1.59%) Shareholding of Promoter and Promoter Group
Jay Hemant Bhagat 83600.0 (1.11%) Shareholding of Promoter and Promoter Group
Padmaben Chandravadan Bhagat 40000.0 (0.53%) Shareholding of Promoter and Promoter Group
Naynaben Chandravadan Bhagat 32000.0 (0.42%) Shareholding of Promoter and Promoter Group
Lopa Mahesh Bhagat 8000.0 (0.11%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Chandra Bhagat Pharma Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Chandra Bhagat Pharma Limited Share Price

Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10, 2003. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20, 2019.

The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late. Shree Chandravadan Bhagat. On April 1, 2003, the Company acquired the going concern business of M/s. Chandra Bhagat Corporation, partnership firm along with all its assets and liabilities. Consequently, the Company issued equity shares to respective partners of M/s. Chandra Bhagat Corporation upon the acquisition of going concern business.

Thereafter, the Promoter Mr. Hemant Bhagat continued the business on the footsteps of his father Late Shree Chandravadan Bhagat by focusing on marketing of life saving medicines like Antibiotics, Antineoplastic, Cardiovascular, Hormones etc. and set up the Company's marketing force to wider the product portfolio. Subsequently in 2004, the Promoters, Mr. Pranav Bhagat son of Mr. Hemant Bhagat, joined the business and decided to market the pharmaceuticals and special chemical products in domestic as well as in international market.

The Company is engaged in the business of marketing pharmaceutical critical care & health care products. For which it obtained necessary approvals from FDA for getting the formulations manufacture from contract manufacturers. At present, the Company has a wide range of products portfolio of pharmaceutical formulation including IV & IM range Injections, few tablets to cater the Domestic & Export Market. It has established presence in major therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anaesthesia, Hormones, Orthopaedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Paediatrics, Cardiology, Nephrology, Neurology etc. It is engaged in promoting and marketing of Active Pharmaceuticals Ingredients (API's) in India.

Parent organization Indian Private
NSE symbol [-]
Founded 2003
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Chandra Bhagat Pharma Ltd?

Answer Field

The share price of Chandra Bhagat Pharma Ltd for NSE is ₹ 0.00 and for BSE is ₹ 60.00.

What is the Market Cap of Chandra Bhagat Pharma Ltd?

Answer Field

The market cap of Chandra Bhagat Pharma Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 45.30 Cr. as of now.

What is the 52 Week High and Low of Chandra Bhagat Pharma Ltd?

Answer Field

The 52 Week High and Low of Chandra Bhagat Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 124.25 and ₹ 50.00.

How to Buy Chandra Bhagat Pharma Ltd share?

Answer Field

You can trade in Chandra Bhagat Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Chandra Bhagat Pharma Ltd?

Answer Field

The 1 year returns on the stock has been -47.75%.

What is the Current Share Price of Chandra Bhagat Pharma Ltd?

Answer Field

Chandra Bhagat Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 60.00 as on Apr 17 2025 12:00 AM.

What is the Market Cap of Chandra Bhagat Pharma Ltd Share?

Answer Field

The market cap of Chandra Bhagat Pharma Ltd for NSE ₹ 0.0 & for BSE ₹ 45.30 as on Apr 17 2025 12:00 AM.

What is the P/E Ratio of Chandra Bhagat Pharma Ltd Share?

Answer Field

As on Apr 17 2025 12:00 AM the price-to-earnings (PE) ratio for Chandra Bhagat Pharma Ltd share is 29.56.

What is the PB ratio of Chandra Bhagat Pharma Ltd Share?

Answer Field

As on Apr 17 2025 12:00 AM, the price-to-book (PB) ratio for Chandra Bhagat Pharma Ltd share is 38.44.

How to Buy Chandra Bhagat Pharma Ltd Share?

Answer Field

You can trade in Chandra Bhagat Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Chandra Bhagat Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Chandra Bhagat Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Chandra Bhagat Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|